Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
43.41
-0.42 (-0.96%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Medline Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 1,159 | 1,200 | 234 | -25 |
| Depreciation & Amortization | 1,011 | 977 | 951 | 933 |
| Other Amortization | 59 | 57 | 80 | 85 |
| Loss (Gain) From Sale of Assets | - | - | - | 6 |
| Stock-Based Compensation | 76 | 61 | 78 | 64 |
| Provision & Write-off of Bad Debts | 54 | 63 | 8 | 29 |
| Other Operating Activities | 168 | 86 | 135 | 14 |
| Change in Accounts Receivable | -355 | -256 | -153 | -376 |
| Change in Inventory | -264 | -545 | 444 | -195 |
| Change in Accounts Payable | 73 | 106 | 136 | -103 |
| Change in Other Net Operating Assets | -237 | 20 | -228 | -245 |
| Operating Cash Flow | 1,744 | 1,769 | 1,685 | 187 |
| Operating Cash Flow Growth | -1.41% | 4.98% | 801.07% | - |
| Capital Expenditures | -480 | -364 | -285 | -254 |
| Cash Acquisitions | 6 | -1,126 | -16 | -17 |
| Investment in Securities | - | - | - | 7 |
| Other Investing Activities | - | -3 | -11 | - |
| Investing Cash Flow | -474 | -1,493 | -312 | -264 |
| Short-Term Debt Issued | 179 | 166 | - | 80 |
| Long-Term Debt Issued | 7,569 | 15,932 | - | - |
| Total Debt Issued | 7,748 | 16,098 | - | 80 |
| Short-Term Debt Repaid | -179 | -166 | - | -80 |
| Long-Term Debt Repaid | -11,697 | -15,995 | -77 | -61 |
| Total Debt Repaid | -11,876 | -16,161 | -77 | -141 |
| Net Debt Issued (Repaid) | -4,128 | -63 | -77 | -61 |
| Issuance of Common Stock | 7,048 | - | - | - |
| Repurchase of Common Stock | -2,003 | -20 | - | - |
| Common Dividends Paid | -518 | -1,518 | -114 | -23 |
| Other Financing Activities | - | -12 | - | - |
| Financing Cash Flow | 399 | -1,613 | -191 | -84 |
| Foreign Exchange Rate Adjustments | 23 | 2 | 4 | -30 |
| Net Cash Flow | 1,692 | -1,335 | 1,186 | -191 |
| Free Cash Flow | 1,264 | 1,405 | 1,400 | -67 |
| Free Cash Flow Growth | -10.04% | 0.36% | - | - |
| Free Cash Flow Margin | 4.45% | 5.51% | 6.03% | -0.31% |
| Free Cash Flow Per Share | 1.56 | 0.08 | 0.08 | - |
| Cash Interest Paid | 944 | 1,022 | 1,126 | 800 |
| Cash Income Tax Paid | 62 | 101 | 52 | 54 |
| Levered Free Cash Flow | 791.25 | 759.5 | - | - |
| Unlevered Free Cash Flow | 1,323 | 1,418 | - | - |
| Change in Working Capital | -783 | -675 | 199 | -919 |
Source: S&P Capital IQ. Standard template. Financial Sources.